Your browser doesn't support javascript.
loading
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
Giovannoni, Gavin; Soelberg Sorensen, Per; Cook, Stuart; Rammohan, Kottil W; Rieckmann, Peter; Comi, Giancarlo; Dangond, Fernando; Hicking, Christine; Vermersch, Patrick.
Afiliação
  • Giovannoni G; Department of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Soelberg Sorensen P; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Cook S; Department of Neurology & Neurosciences, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, USA.
  • Rammohan KW; MS Research Center, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Rieckmann P; Department of Neurology, Hospital for Nervous Diseases, Medical Park Loipl, Bischofswiesen, Germany/University of Erlangen-Nürnberg, Erlangen, Germany.
  • Comi G; Department of Neurology, Università Vita-Salute San Raffaele and Institute of Experimental Neurology, Ospedale San Raffaele, Milan, Italy.
  • Dangond F; EMD Serono, Inc., Billerica, MA, USA.
  • Hicking C; Merck KGaA, Darmstadt, Germany.
  • Vermersch P; University of Lille, CHU Lille, LIRIC-INSERM U995, FHU Imminent, Lille, France.
Mult Scler ; 25(6): 819-827, 2019 05.
Article em En | MEDLINE | ID: mdl-29716436
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Cladribina / Progressão da Doença / Esclerose Múltipla Recidivante-Remitente / Imunossupressores Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Cladribina / Progressão da Doença / Esclerose Múltipla Recidivante-Remitente / Imunossupressores Idioma: En Ano de publicação: 2019 Tipo de documento: Article